NASDAQ:DYAI Dyadic International (DYAI) Stock Price, News & Analysis $1.26 -0.01 (-0.79%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$1.22▼$1.3350-Day Range$1.26▼$1.5552-Week Range$1.13▼$2.67Volume18,696 shsAverage Volume54,463 shsMarket Capitalization$36.84 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Dyadic International alerts: Email Address Dyadic International MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside376.2% Upside$6.00 Price TargetShort InterestHealthy0.74% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.26) to ($0.22) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.16 out of 5 starsMedical Sector500th out of 910 stocksBiological Products, Except Diagnostic Industry75th out of 155 stocks 3.5 Analyst's Opinion Consensus RatingDyadic International has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageDyadic International has only been the subject of 1 research reports in the past 90 days.Read more about Dyadic International's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.74% of the float of Dyadic International has been sold short.Short Interest Ratio / Days to CoverDyadic International has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Dyadic International has recently increased by 20.62%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldDyadic International does not currently pay a dividend.Dividend GrowthDyadic International does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DYAI. Previous Next N/A News and Social Media Coverage Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Dyadic International insiders have not sold or bought any company stock.Percentage Held by Insiders28.80% of the stock of Dyadic International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 27.95% of the stock of Dyadic International is held by institutions.Read more about Dyadic International's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Dyadic International are expected to grow in the coming year, from ($0.26) to ($0.22) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Dyadic International is -4.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Dyadic International is -4.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDyadic International has a P/B Ratio of 11.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Dyadic International's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Dyadic International Stock (NASDAQ:DYAI)Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.Read More DYAI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DYAI Stock News HeadlinesAugust 14, 2024 | seekingalpha.comDyadic International, Inc. (DYAI) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | markets.businessinsider.comDyadic International is about to announce its earnings — here's what to expectSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. July 30, 2024 | globenewswire.comDyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024June 28, 2024 | globenewswire.comDyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization PartnershipMay 30, 2024 | globenewswire.comDyadic to Attend Industry Events in JuneMay 19, 2024 | msn.comDyadic International, Inc. (NASDAQ:DYAI) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comDYAI: Product Revenues Next YearSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. May 15, 2024 | finance.yahoo.comDyadic International Inc (DYAI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review ...May 14, 2024 | investorplace.comDYAI Stock Earnings: Dyadic International Reported Results for Q1 2024May 14, 2024 | msn.comDyadic International GAAP EPS of -$0.07, revenue of $0.34MMay 14, 2024 | globenewswire.comDyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 14, 2024 | investing.comDyadic (DYAI) Earnings Dates & ReportsMay 8, 2024 | globenewswire.comDyadic to Attend Industry and Investor Events in MayMay 7, 2024 | investing.comDyadic International Inc (DYAI)May 4, 2024 | fool.comDyadic International (NASDAQ: DYAI)April 30, 2024 | globenewswire.comDyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024See More Headlines Receive DYAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dyadic International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/13/2024Today9/07/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:DYAI CUSIPN/A CIK1213809 Webwww.dyadic.com Phone(561) 743-8333Fax561-743-8343Employees7Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$6.00 Low Stock Price Target$6.00 Potential Upside/Downside+376.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,800,000.00 Net Margins-428.86% Pretax Margin-428.86% Return on Equity-145.95% Return on Assets-75.92% Debt Debt-to-Equity Ratio1.72 Current Ratio5.39 Quick Ratio5.39 Sales & Book Value Annual Sales$1.80 million Price / Sales20.42 Cash FlowN/A Price / Cash FlowN/A Book Value$0.11 per share Price / Book11.45Miscellaneous Outstanding Shares29,237,000Free Float20,817,000Market Cap$36.84 million OptionableOptionable Beta0.73 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Mark A. Emalfarb (Age 68)Founder, CEO, President & Director Comp: $874.37kMs. Ping Wang Rawson CPA (Age 48)M.B.A., Chief Financial Officer Comp: $348.42kMr. Joseph P. Hazelton (Age 48)Chief Operating Officer Comp: $358.12kMr. Doug Pace B.A.Executive Vice President of Business DevelopmentMs. Ana Gómez RodriguezSecretary of the BoardKey CompetitorsBrainstorm Cell TherapeuticsNASDAQ:BCLIChampions OncologyNASDAQ:CSBRLogicBio TherapeuticsNASDAQ:LOGCGeneration BioNASDAQ:GBIOLifecore BiomedicalNASDAQ:LFCRView All CompetitorsInstitutional OwnershipChapin Davis Inc.Bought 21,000 shares on 7/19/2024Ownership: 2.898%View All Institutional Transactions DYAI Stock Analysis - Frequently Asked Questions How have DYAI shares performed this year? Dyadic International's stock was trading at $1.61 at the beginning of 2024. Since then, DYAI shares have decreased by 21.7% and is now trading at $1.26. View the best growth stocks for 2024 here. How were Dyadic International's earnings last quarter? Dyadic International, Inc. (NASDAQ:DYAI) released its earnings results on Tuesday, August, 13th. The biotechnology company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The biotechnology company had revenue of $0.39 million for the quarter, compared to analyst estimates of $1 million. Dyadic International had a negative net margin of 428.86% and a negative trailing twelve-month return on equity of 145.95%. Who are Dyadic International's major shareholders? Top institutional investors of Dyadic International include Chapin Davis Inc. (2.90%). Insiders that own company stock include Ronen Tchelet and Mark A Emalfarb. View institutional ownership trends. How do I buy shares of Dyadic International? Shares of DYAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Dyadic International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dyadic International investors own include Silvercorp Metals (SVM), Endeavour Silver (EXK), Hecla Mining (HL), Pfizer (PFE), Advanced Micro Devices (AMD), Endeavour Silver (EDR) and Mandalay Resources (MND). This page (NASDAQ:DYAI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyadic International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyadic International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
